Viewpoint: Congress has put a bull’s-eye on life sciences economy


Legislation penned by U.S. Senators Chuck Schumer, D-N.Y., and Joe Manchin, D-W.Va., ostensibly to fight inflation will slow the development of new cures, hammer the regional economy, and actually make drugs less affordable over time.

The legislation is often described as giving the government the ability to “negotiate” prices. The legislation does much more than that because any company that does not comply with the government’s requested price will see 95% of the revenue from that drug confiscated…

Previous Seacoast to acquire Professional Bank in deal valued at $488M
Next Pfizer to buy Peninsula sickle cell disease drug maker for $5.4 billion